Quest Diagnostics Incorporated DGX
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 16.51% | 11.79% | 14.16% | 13.89% | 15.22% |
| Total Depreciation and Amortization | 4.46% | 6.81% | 11.61% | 15.62% | 19.91% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.17% | 30.13% | 72.43% | 60.23% | 126.17% |
| Change in Net Operating Assets | -410.53% | 15.91% | 33.33% | 124.88% | 131.67% |
| Cash from Operations | 3.50% | 13.41% | 23.83% | 41.38% | 34.93% |
| Capital Expenditure | -17.07% | -22.03% | -19.63% | -24.00% | -31.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 79.49% | 93.69% | 93.13% | 95.33% | 75.63% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 218.75% | -115.38% | -150.00% | -107.32% | -220.00% |
| Cash from Investing | 31.42% | 71.44% | 72.73% | 75.24% | 56.39% |
| Total Debt Issued | 20.49% | -77.56% | -90.54% | -77.79% | -85.01% |
| Total Debt Repaid | 50.10% | 48.95% | 54.26% | -233.99% | -40.56% |
| Issuance of Common Stock | 53.66% | 35.63% | 27.78% | 8.22% | 28.13% |
| Repurchase of Common Stock | -71.88% | -205.67% | -152.58% | -182.86% | -15.38% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -6.34% | -6.14% | -6.25% | -6.65% | -6.12% |
| Other Financing Activities | -55.93% | -43.75% | 30.95% | 34.62% | 14.49% |
| Cash from Financing | 26.12% | -222.65% | -244.82% | -228.04% | -191.84% |
| Foreign Exchange rate Adjustments | 75.00% | -50.00% | 133.33% | 157.14% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 209.94% | 539.58% | 171.68% | 5.84% | -153.46% |